Name: The Time They Are A-Changin'
Start: 2013-10-07T05:00

Why Fish

Diversity, Equity & Inclusion

Pro Bono

Partner Organizations

Legal Operations

Pricing

Legal Project Management

Knowledge Management

eDiscovery

Legal Technology Services

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Appellate

Chancery & Corporate Governance

Post-Grant

Inter Partes Review

Post-Grant Review

Ex Parte Reexamination

Supplemental Examination

Patent

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Industries

Electrical & Computer Technology

Artificial Intelligence

Digital Health

Digital Media & E-Commerce

Financial, Business & FinTech Services

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Post-Grant Annual Reports

Hosts

Name

Sean P. Daley, Ph.D.

Person title

Senior Principal

Fish Principals Matt Samuel and Sean Daley spoke at this Global Counsel Leaders Circle Members Conference.

The Time They Are A-Changin'

Hosts

PLI Patenting Blockchain and Distributed Ledger Technologies 2023

Minnesota Patent Litigation Wrap-Up: Q3 2023

ITC Monthly Wrap-Up: October 2023

Legal Alert: FTC Challenges More Than 100 Patents as Improperly Listed in Orange Book

District of Delaware Finds Allergan Patents Invalid for Lack of Written Description and Obviousness-Type Double Patenting in Allergan v. MSN Labs

Texas Patent Litigation Monthly Wrap-Up: October 2023

District of Delaware Finds Non-Orange Book-Listed Patents Subject to the Same Pleading Standard as Listed Patents in ANDA Infringement Suit

ITC Monthly Wrap-Up: September 2023

Federal Circuit Evaluates Enablement for Antibody Claims for the First Time Since Amgen v. Sanofi in Baxalta Inc. et al. v. Genentech, Inc.

ITC Monthly Wrap-Up: August 2023

Minnesota Patent Litigation Wrap-Up: Q2 2023